240 related articles for article (PubMed ID: 25685782)
1. Natural compounds regulate glycolysis in hypoxic tumor microenvironment.
Gao JL; Chen YG
Biomed Res Int; 2015; 2015():354143. PubMed ID: 25685782
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1.
Kim JW; Gao P; Liu YC; Semenza GL; Dang CV
Mol Cell Biol; 2007 Nov; 27(21):7381-93. PubMed ID: 17785433
[TBL] [Abstract][Full Text] [Related]
3. The determinants of metabolic discrepancies in aerobic glycolysis: Providing potential targets for breast cancer treatment.
Littleflower AB; Parambil ST; Antony GR; Subhadradevi L
Biochimie; 2024 May; 220():107-121. PubMed ID: 38184121
[TBL] [Abstract][Full Text] [Related]
4. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer.
Yeung SJ; Pan J; Lee MH
Cell Mol Life Sci; 2008 Dec; 65(24):3981-99. PubMed ID: 18766298
[TBL] [Abstract][Full Text] [Related]
5. Flavonoids Targeting HIF-1: Implications on Cancer Metabolism.
Samec M; Liskova A; Koklesova L; Mersakova S; Strnadel J; Kajo K; Pec M; Zhai K; Smejkal K; Mirzaei S; Hushmandi K; Ashrafizadeh M; Saso L; Brockmueller A; Shakibaei M; Büsselberg D; Kubatka P
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401572
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA regulation and analytical methods in cancer cell metabolism.
Zhang LF; Jiang S; Liu MF
Cell Mol Life Sci; 2017 Aug; 74(16):2929-2941. PubMed ID: 28321489
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells.
Luo W; Semenza GL
Oncotarget; 2011 Jul; 2(7):551-6. PubMed ID: 21709315
[TBL] [Abstract][Full Text] [Related]
8. GLUT and HK: Two primary and essential key players in tumor glycolysis.
Yadav D; Yadav A; Bhattacharya S; Dagar A; Kumar V; Rani R
Semin Cancer Biol; 2024 May; 100():17-27. PubMed ID: 38494080
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy.
Ni X; Lu CP; Xu GQ; Ma JJ
Acta Pharmacol Sin; 2024 Apr; ():. PubMed ID: 38622288
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated glycolysis as an oncogenic event.
Mikawa T; LLeonart ME; Takaori-Kondo A; Inagaki N; Yokode M; Kondoh H
Cell Mol Life Sci; 2015 May; 72(10):1881-92. PubMed ID: 25609364
[TBL] [Abstract][Full Text] [Related]
11. Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment.
Xu W; Weng J; Xu M; Zhou Q; Liu S; Hu Z; Ren N; Zhou C; Shen Y
Cell Reprogram; 2023 Jun; 25(3):91-98. PubMed ID: 37172278
[TBL] [Abstract][Full Text] [Related]
12. Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target.
Zhao J; Jin D; Huang M; Ji J; Xu X; Wang F; Zhou L; Bao B; Jiang F; Xu W; Lu X; Xiao M
Front Cell Dev Biol; 2024; 12():1416472. PubMed ID: 38933335
[TBL] [Abstract][Full Text] [Related]
13. Alteration of glucose metabolism and expression of glucose transporters in ovarian cancer.
Ben Ali F; Qmichou Z; Oukabli M; Dakka N; Bakri Y; Eddouks M; Ameziane El Hassani R
Explor Target Antitumor Ther; 2024; 5(2):384-399. PubMed ID: 38745772
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Reprogramming in Thyroid Carcinoma.
Coelho RG; Fortunato RS; Carvalho DP
Front Oncol; 2018; 8():82. PubMed ID: 29629339
[TBL] [Abstract][Full Text] [Related]
15. Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question.
Alfarouk KO; Verduzco D; Rauch C; Muddathir AK; Adil HH; Elhassan GO; Ibrahim ME; David Polo Orozco J; Cardone RA; Reshkin SJ; Harguindey S
Oncoscience; 2014; 1(12):777-802. PubMed ID: 25621294
[TBL] [Abstract][Full Text] [Related]
16. Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer.
Fahrmann JF; Vykoukal JV; Ostrin EJ
Front Oncol; 2020; 10():276. PubMed ID: 32266129
[TBL] [Abstract][Full Text] [Related]
17. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.
Courtnay R; Ngo DC; Malik N; Ververis K; Tortorella SM; Karagiannis TC
Mol Biol Rep; 2015 Apr; 42(4):841-51. PubMed ID: 25689954
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality.
McIntyre A; Harris AL
EMBO Mol Med; 2015 Apr; 7(4):368-79. PubMed ID: 25700172
[TBL] [Abstract][Full Text] [Related]
19. Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis.
Prabhu A; Sarcar B; Miller CR; Kim SH; Nakano I; Forsyth P; Chinnaiyan P
Neuro Oncol; 2015 Sep; 17(9):1220-30. PubMed ID: 25712957
[TBL] [Abstract][Full Text] [Related]
20. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
Zhan C; Yan L; Wang L; Ma J; Jiang W; Zhang Y; Shi Y; Wang Q
PLoS One; 2015; 10(3):e0118663. PubMed ID: 25738776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
